Pub Date : 2024-01-01Epub Date: 2023-08-18DOI: 10.2337/cd23-0018
Erica Wee, Erica Zarse, Lindsay Baldridge, Jaimie Contreras, Emily DeWit, Heather Feingold, Mark Clements, Sonalee Ravi
Quality Improvement Success Stories are published by the American Diabetes Association in collaboration with the American College of Physicians and the National Diabetes Education Program. This series is intended to highlight best practices and strategies from programs and clinics that have successfully improved the quality of care for people with diabetes or related conditions. Each article in the series is reviewed and follows a standard format developed by the editors of Clinical Diabetes. The following article describes efforts at a large midwestern pediatric health system to improve planning for patients' transition from pediatric to adult diabetes care settings.
{"title":"Improving Planning for Transition to Adult Care in a Pediatric Diabetes Clinic.","authors":"Erica Wee, Erica Zarse, Lindsay Baldridge, Jaimie Contreras, Emily DeWit, Heather Feingold, Mark Clements, Sonalee Ravi","doi":"10.2337/cd23-0018","DOIUrl":"10.2337/cd23-0018","url":null,"abstract":"<p><p>Quality Improvement Success Stories are published by the American Diabetes Association in collaboration with the American College of Physicians and the National Diabetes Education Program. This series is intended to highlight best practices and strategies from programs and clinics that have successfully improved the quality of care for people with diabetes or related conditions. Each article in the series is reviewed and follows a standard format developed by the editors of <i>Clinical Diabetes</i>. The following article describes efforts at a large midwestern pediatric health system to improve planning for patients' transition from pediatric to adult diabetes care settings.</p>","PeriodicalId":39894,"journal":{"name":"Clinical Diabetes","volume":" ","pages":"156-160"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10788670/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41488147","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-01-01Epub Date: 2023-09-07DOI: 10.2337/cd23-0056
Joyce M Lee, Emma Ospelt, Nudrat Noor, Ann Mungmode, Osagie Ebekozien, Meenal Gupta, Faisal S Malik, Naomi R Fogel, Siham Accacha, Susan Hsieh, Meredith Wilkes, Anna Neyman, Francesco Vendrame
The aim of this study was to describe rates of telemedicine use 18 months after the start of the coronavirus disease 2019 pandemic and to assess the institutional barriers to its implementation for type 1 diabetes care across centers of the T1D Exchange Quality Improvement Collaborative. Observational electronic health record data capturing telemedicine rates from 15 U.S. centers between September 2020 and September 2021 and a survey of 33 centers capturing telemedicine rates and key components of telemedicine were analyzed. A capacity score was developed and summed to a total capacity score and compared with overall telemedicine rates across centers. Telemedicine visits decreased by 17.4% from September 2020 to September 2021. Generally, it was observed that the lower the average telemedicine capacity score, the lower the rate of telemedicine visits. Despite a decline in the utilization of telemedicine 18 months after the start of the pandemic, visit rates were still 20% higher than in the pre-pandemic period. However, there is a need to improve structural components to ensure telemedicine capacity and robust telemedicine utilization.
{"title":"Institutional Barriers to the Successful Implementation of Telemedicine for Type 1 Diabetes Care.","authors":"Joyce M Lee, Emma Ospelt, Nudrat Noor, Ann Mungmode, Osagie Ebekozien, Meenal Gupta, Faisal S Malik, Naomi R Fogel, Siham Accacha, Susan Hsieh, Meredith Wilkes, Anna Neyman, Francesco Vendrame","doi":"10.2337/cd23-0056","DOIUrl":"10.2337/cd23-0056","url":null,"abstract":"<p><p>The aim of this study was to describe rates of telemedicine use 18 months after the start of the coronavirus disease 2019 pandemic and to assess the institutional barriers to its implementation for type 1 diabetes care across centers of the T1D Exchange Quality Improvement Collaborative. Observational electronic health record data capturing telemedicine rates from 15 U.S. centers between September 2020 and September 2021 and a survey of 33 centers capturing telemedicine rates and key components of telemedicine were analyzed. A capacity score was developed and summed to a total capacity score and compared with overall telemedicine rates across centers. Telemedicine visits decreased by 17.4% from September 2020 to September 2021. Generally, it was observed that the lower the average telemedicine capacity score, the lower the rate of telemedicine visits. Despite a decline in the utilization of telemedicine 18 months after the start of the pandemic, visit rates were still 20% higher than in the pre-pandemic period. However, there is a need to improve structural components to ensure telemedicine capacity and robust telemedicine utilization.</p>","PeriodicalId":39894,"journal":{"name":"Clinical Diabetes","volume":" ","pages":"34-39"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10788657/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47282926","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-01-01Epub Date: 2024-04-15DOI: 10.2337/cd24-a014
{"title":"Section 14: Children and Adolescents.","authors":"","doi":"10.2337/cd24-a014","DOIUrl":"https://doi.org/10.2337/cd24-a014","url":null,"abstract":"","PeriodicalId":39894,"journal":{"name":"Clinical Diabetes","volume":"42 2","pages":"218-219"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11040030/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140870142","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-01-01Epub Date: 2024-04-15DOI: 10.2337/cd24-a008
{"title":"Section 8: Obesity and Weight Management for the Prevention and Treatment of Type 2 Diabetes.","authors":"","doi":"10.2337/cd24-a008","DOIUrl":"https://doi.org/10.2337/cd24-a008","url":null,"abstract":"","PeriodicalId":39894,"journal":{"name":"Clinical Diabetes","volume":"42 2","pages":"204-205"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11040025/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140867696","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-01-01Epub Date: 2024-04-15DOI: 10.2337/cd24-aint
{"title":"Introduction: <i>Standards of Care in Diabetes-2024</i> Abridged for Primary Care Professionals.","authors":"","doi":"10.2337/cd24-aint","DOIUrl":"https://doi.org/10.2337/cd24-aint","url":null,"abstract":"","PeriodicalId":39894,"journal":{"name":"Clinical Diabetes","volume":"42 2","pages":"181"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11040011/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140858336","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-01-01Epub Date: 2023-08-22DOI: 10.2337/cd22-0118
Carolina Solis-Herrera, Michael P Kane, Curtis Triplitt
Oral administration of peptide therapeutics faces challenges because of the distinct environment of the gastrointestinal tract. An oral formulation of semaglutide, a glucagon-like peptide 1 receptor agonist, was approved by the U.S. Food and Drug Administration in 2019 as a peptide therapy for the treatment of type 2 diabetes. Oral semaglutide uses sodium N-(8-[2-hydroxybenzoyl] amino) caprylate (SNAC) technology to enhance the absorption of semaglutide in the stomach and protect it from degradation by gastric enzymes. This article presents a summary of studies investigating SNAC technology as an absorption enhancer for a number of molecules and, in particular, explores how SNAC, once coformulated with oral semaglutide, facilitates increased absorption and bioavailability. Practical advice and dispensing information for pharmacists is also provided.
{"title":"Current Understanding of Sodium N-(8-[2-Hydroxylbenzoyl] Amino) Caprylate (SNAC) as an Absorption Enhancer: The Oral Semaglutide Experience.","authors":"Carolina Solis-Herrera, Michael P Kane, Curtis Triplitt","doi":"10.2337/cd22-0118","DOIUrl":"10.2337/cd22-0118","url":null,"abstract":"<p><p>Oral administration of peptide therapeutics faces challenges because of the distinct environment of the gastrointestinal tract. An oral formulation of semaglutide, a glucagon-like peptide 1 receptor agonist, was approved by the U.S. Food and Drug Administration in 2019 as a peptide therapy for the treatment of type 2 diabetes. Oral semaglutide uses sodium N-(8-[2-hydroxybenzoyl] amino) caprylate (SNAC) technology to enhance the absorption of semaglutide in the stomach and protect it from degradation by gastric enzymes. This article presents a summary of studies investigating SNAC technology as an absorption enhancer for a number of molecules and, in particular, explores how SNAC, once coformulated with oral semaglutide, facilitates increased absorption and bioavailability. Practical advice and dispensing information for pharmacists is also provided.</p>","PeriodicalId":39894,"journal":{"name":"Clinical Diabetes","volume":" ","pages":"74-86"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10788673/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42572058","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-01-01Epub Date: 2024-04-15DOI: 10.2337/cd24-a004
{"title":"Section 4: Comprehensive Medical Evaluation and Assessment of Comorbidities.","authors":"","doi":"10.2337/cd24-a004","DOIUrl":"https://doi.org/10.2337/cd24-a004","url":null,"abstract":"","PeriodicalId":39894,"journal":{"name":"Clinical Diabetes","volume":"42 2","pages":"189-192"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11040026/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140866816","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-01-01Epub Date: 2024-01-15DOI: 10.2337/cd23-0095
Jay H Shubrook
{"title":"Improving Care for People With Type 1 Diabetes.","authors":"Jay H Shubrook","doi":"10.2337/cd23-0095","DOIUrl":"10.2337/cd23-0095","url":null,"abstract":"","PeriodicalId":39894,"journal":{"name":"Clinical Diabetes","volume":"42 1","pages":"10-11"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10788669/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139479510","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
扫码关注我们
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号